Can Body Fat Cause Aortic Stenosis?: Lessons From Genetics by Oury, Cécile et al.
This article appeared in a journal published by Elsevier. The attached
copy is furnished to the author for internal non-commercial research
and education use, including for instruction at the author's
institution and sharing with colleagues.
Other uses, including reproduction and distribution, or selling or
licensing copies, or posting to personal, institutional or third party
websites are prohibited.
In most cases authors are permitted to post their version of the
article (e.g. in Word or Tex form) to their personal website or
institutional repository. Authors requiring further information
regarding Elsevier's archiving and manuscript policies are
encouraged to visit:
http://www.elsevier.com/authorsrights
J O U R N A L O F T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y V O L . 7 5 , N O . 2 , 2 0 2 0
ª 2 0 2 0 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O UN DA T I O N
P U B L I S H E D B Y E L S E V I E R
Author's Personal CopyEDITORIAL COMMENTCan Body Fat Cause Aortic Stenosis?
Lessons From Genetics*Cécile Oury, PHD, Nathalie Donis, MSC, Patrick Marechal, MDSEE PAGE 163D egenerative aortic stenosis (AS) is the mostcommon valvular heart disease in industri-alized countries, with a prevalence
reaching #13% above 75 years of age. Due to popula-
tion ageing, a steadily increase of AS prevalence is
foreseen in the years to come. AS is a progressive
and insidious disease that remains asymptomatic
for a very long time. Long-lasting valve dysfunction
results in left ventricle remodeling and cardiac im-
pairments that are often irreversible at symptom
onset. Hence, AS is a disease of the valve and of the
myocardium, resulting in inevitable fatal outcome if
left untreated. There are currently no pharmacother-
apies that can halt or delay AS progression, the only
treatment being aortic valve replacement (AVR)
(1,2). It is therefore crucial to identify risk factors of
the disease to adopt optimal management measures
and reduce AS burden. A recent study performed on
71,817 individuals from the Cohort of Swedish Men
and the Swedish Mammography Cohort indicated
that increases of body mass index (BMI) and waist
circumference were associated with the incidence of
aortic stenosis (3). This study was the first strong
indication that obesity might represent a major risk
factor of AS. This observation was likely to have a
major impact on human health. Indeed, according
to the most recent global estimates by the World
Health Organization, about 13% of the world’s adult
population (11% of men and 15% of women) were
obese in 2016, and these numbers are expected toISSN 0735-1097/$36.00
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ered a leading cause of increased AS prevalence.
Obesity, defined as a BMI $30, globally develops
due to increased intake of fat-rich, energy-dense
foods and physical inactivity related to environ-
mental and societal habits (Figure 1). On top of these
modifiable factors, genetics determines the suscepti-
bility of individuals to become obese. Largescale
studies identified >125 common gene loci associated
with different measures of obesity (4). The analysis
of these variants in the general population can pro-
vide important information in regard to the existence
of causal relationship between phenotypic traits, i.e.,
obesity and the risk of diseases. By applying so-called
Mendelian randomization technique, it is indeed
possible to examine the causal effect of obesity on
AS by measured variation in genes that have beenassociated with obesity. Kaltoft et al. (5) are to be
commended on their carefully conducted Mendelian
randomization study, in this issue of the Journal,
exploring the association of genetically determined
obesity with risk of AS. A total of 108,211 individuals
from the Copenhagen General Population Study were
included in their study. The incidence of AS in this
population was 982, and 409 AVR, during a median
follow-up of 8.7 years. The investigators nicely
demonstrated that individuals who were genetically
susceptible to become obese, based on interrogation
of the 5 top common genetic variants that have
been associated with BMI (6), had higher risk of AS
and AVR. Individuals were categorized by defining
unweighted allele scores for BMI so that the investi-
gators could show that individuals who were geneti-
cally more likely to be obese had an increased
hazard ratio for AS. In addition to the genetic anal-
ysis, Kaltoft et al. (5) also measured BMI and waist-
hip ratio (WHR) at inclusion. It was found thathttps://doi.org/10.1016/j.jacc.2019.11.017




















Genetic variants associated with obesity are associated with aortic stenosis, supporting the existence of a causal link between obesity and this
disease. AS ¼ aortic stenosis; BMI ¼ body mass index; Circ. ¼ circumference; CV ¼ cardiovascular; CMR ¼ cardiac magnetic resonance.
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ment of 1 kg/m2 increased the causal risk ratios for
aortic valve stenosis and replacement. A similar
observation was made for WHR increases. It was
therefore concluded that obesity was, observation-
ally on the basis of BMI and WHR and causally on
the basis of BMI genetics, associated with higher
risk of AS and AVR.
A major limitation of Mendelian randomization
relates to possible pleiotropic effects of the genetic
variants used, i.e., single genetic variants can affect
multiple phenotypic traits, which means that this
approach may not necessarily provide a proof of
causality (7). In the study by Kaltoft et al. (5), the use
of allele scoring contributes to overcome this poten-
tial bias, which greatly strengthens their findings.
Recently, Mendelian randomization has contrib-
uted to our understanding of how lipid biology relates
to cardiovascular risk (8,9). Besides, thanks to
comprehensive largescale exome sequencing, novel
low-frequency or rare (minor allele frequency <5%)
coding variants, with relatively larger effects than
common (minor allele frequency >5%) noncoding
variants (10), are being discovered, highlighting po-
tential causal genes underlying previously identified
body-fat distribution loci (4). Such discoveriesrepresent a major advance in our understanding of
the biology and genetic architecture of central
obesity. Whether central obesity is genetically asso-
ciated with AS or AVR remains to be determined.
Exploiting these new findings in Mendelian random-
ization studies may help in defining the association of
central obesity with AS risk and understanding how
lipid imbalance relates to AS risk, thereby providing
new insights into AS etiology. Further, the identifi-
cation of causal gene variants of body-fat distribution
that would be associated with AS could reveal po-
tential new therapeutic targets for preventive in-
terventions. In addition to abdominal visceral fat, it
would be interesting to assess the genetic association
of epicardial fat, a visceral fat deposit located be-
tween the heart and the pericardium, with AS or AVR.
Indeed, it has recently been reported that the
epicardial fat volume, obtained by cardiac magnetic
resonance imaging, may predict AS outcome (11), and
unique gene loci appeared to be associated with
pericardial fat (12).
In addition to well-known and presently demon-
strated causal effects of increased BMI on cardio-
vascular and AS risk, raised BMI is also a risk factor
for diabetes. There is evidence that type 2 diabetes
mellitus predisposes to degenerative AS and
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Author's Personal Copycontributes to faster progression of AS. Moreover,
diabetes is an independent determinant of cardio-
vascular mortality in patients with severe AS (13). We
can then assume that studying the association of
genetic variants related to combined raised BMI and
diabetes mellitus with lifetime AS risk could be even
more powerful than studies of isolated phenotypic
traits. We believe that cross-trait association Men-
delian randomization studies could highlight novel
features underpinning patient’s valvulometabolic
and AS risk.The princeps study of Kaltoft et al. (5) will likely be
the basis for other studies intended to refine the
causal link between body fat and AS risk in pop-
ulations of various genetic ancestries.
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